Cargando…
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
Public health threat coming from a rapidly developing COVID-19 pandemic calls for developing safe and effective vaccines with innovative designs. This paper presents preclinical trial results of “Betuvax-CoV-2”, a vaccine developed as a subunit vaccine containing a recombinant RBD-Fc fusion protein...
Autores principales: | Vakhrusheva, Anna V., Kudriavtsev, Aleksandr V., Kryuchkov, Nickolay A., Deev, Roman V., Frolova, Maria E., Blagodatskikh, Konstantin A., Djonovic, Milana, Nedorubov, Andrey A., Odintsova, Elena, Ivanov, Aleksandr V., Romanovskaya-Romanko, Ekaterina A., Stukova, Marina A., Isaev, Artur A., Krasilnikov, Igor V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412395/ https://www.ncbi.nlm.nih.gov/pubmed/36016181 http://dx.doi.org/10.3390/vaccines10081290 |
Ejemplares similares
-
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
por: Kudriavtsev, Aleksandr V., et al.
Publicado: (2023) -
Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2
por: Krasilnikov, Igor V., et al.
Publicado: (2022) -
Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter
por: Sergeeva, M. V., et al.
Publicado: (2022) -
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
por: Kudriavtsev, Aleksandr V., et al.
Publicado: (2022) -
Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)